These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38272379)
1. Should Cannabis be Used for Anorexia in Patients With Cancer? Davis M; Cyr C; Crawford GB; Case AA J Pain Symptom Manage; 2024 May; 67(5):e487-e492. PubMed ID: 38272379 [TBL] [Abstract][Full Text] [Related]
2. Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation. Luckett T; Phillips J; Lintzeris N; Allsop D; Lee J; Solowij N; Martin J; Lam L; Aggarwal R; McCaffrey N; Currow D; Chye R; Lovell M; McGregor I; Agar M Intern Med J; 2016 Nov; 46(11):1269-1275. PubMed ID: 27530738 [TBL] [Abstract][Full Text] [Related]
3. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753 [TBL] [Abstract][Full Text] [Related]
4. The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. Bar-Sela G; Zalman D; Semenysty V; Ballan E Integr Cancer Ther; 2019; 18():1534735419881498. PubMed ID: 31595793 [No Abstract] [Full Text] [Related]
5. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer. Alderman B; Hui D; Mukhopadhyay S; Bouleuc C; Case AA; Amano K; Crawford GB; de Feo G; Sbrana A; Tanco K; To J; Garsed J; Davis M Support Care Cancer; 2022 Dec; 31(1):39. PubMed ID: 36525085 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review. Razmovski-Naumovski V; Luckett T; Amgarth-Duff I; Agar MR Palliat Med; 2022 Jun; 36(6):912-927. PubMed ID: 35360989 [TBL] [Abstract][Full Text] [Related]
7. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Berenstein EG; Ortiz Z Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706 [TBL] [Abstract][Full Text] [Related]
8. Medical use of cannabis products: Lessons to be learned from Israel and Canada. Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992 [TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633 [TBL] [Abstract][Full Text] [Related]
10. Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial. Hunter CN; Abdel-Aal HH; Elsherief WA; Farag DE; Riad NM; Alsirafy SA J Pain Symptom Manage; 2021 Dec; 62(6):1207-1215. PubMed ID: 34051293 [TBL] [Abstract][Full Text] [Related]
11. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Gebbia V; Testa A; Gebbia N Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. Reuter SE; Martin JH Clin Pharmacokinet; 2016 Jul; 55(7):807-812. PubMed ID: 26883879 [TBL] [Abstract][Full Text] [Related]
13. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. Sexton M; Garcia JM; Jatoi A; Clark CS; Wallace MS J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):86-98. PubMed ID: 34850897 [TBL] [Abstract][Full Text] [Related]
14. Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer? Cabeza C; Corsi O; Pérez-Cruz P Medwave; 2017 Dec; 17(9):e7130. PubMed ID: 29286357 [TBL] [Abstract][Full Text] [Related]
15. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk? Abu-Amna M; Salti T; Khoury M; Cohen I; Bar-Sela G Curr Treat Options Oncol; 2021 Jan; 22(2):16. PubMed ID: 33439370 [TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749 [TBL] [Abstract][Full Text] [Related]
18. A Phase II dose titration study of thalidomide for cancer-associated anorexia. Davis M; Lasheen W; Walsh D; Mahmoud F; Bicanovsky L; Lagman R J Pain Symptom Manage; 2012 Jan; 43(1):78-86. PubMed ID: 21640548 [TBL] [Abstract][Full Text] [Related]
19. Medical use of cannabis: Italian and European legislation. Zaami S; Di Luca A; Di Luca NM; Montanari Vergallo G Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1161-1167. PubMed ID: 29509270 [TBL] [Abstract][Full Text] [Related]
20. Cannabis for the treatment of Crohn's disease. Kafil TS; Nguyen TM; MacDonald JK; Chande N Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]